Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Licitra

Showing results (151-160 of 311) with videos related to

Pageof 32
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2014
Radiotherapy for unresectable sinonasal cancers: dosimetric comparison of intensity modulated radiation therapy with coplanar and non-coplanar volumetric modulated arc therapyEster Orlandi, Tommaso Giandini, Eva Iannacone, et al.
Oncology|May 22, 2019
PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor AgentsStefano Cavalieri, Federica Perrone, Massimo Milione, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 5, 2018
Lenvatinib-induced renal failure: two first-time case reports and review of literatureStefano Cavalieri, Laura Cosmai, Augusto Genderini, et al.
Journal of Cancer Research and Clinical Oncology|July 4, 2020
A randomized, double-blind, placebo controlled, phase II study to evaluate the efficacy of ginseng in reducing fatigue in patients treated for head and neck cancerMauro Guglielmo, Patricia Di Pede, Salvatore Alfieri, et al.
Cancers|November 14, 2023
Baseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab TreatmentMarco Carlo Merlano, Matteo Paccagnella, Nerina Denaro, et al.
Head & Neck|November 18, 2018
Impact of treatment expertise on the outcome of patients with head and neck cancer treated within 6 randomized trialsPaolo Bossi, Rosalba Miceli, Marco Benasso, et al.
International Journal of Radiation Oncology, Biology, Physics|September 21, 2007
Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring systemMauro Palazzi, Stefano Tomatis, Ester Orlandi, et al.
Oral Oncology|September 20, 2025
Transcriptomic based prognostic model versus TNM 9th edition in HPV-positive oropharyngeal cancerStefano Cavalieri, Ruud H Brakenhoff, C René Leemans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2018
Molecular Alterations and Buparlisib Efficacy in Patients with Squamous Cell Carcinoma of the Head and Neck: Biomarker Analysis from BERIL-1Denis Soulières, Lisa Licitra, Ricard Mesía, et al.
Head & Neck|January 1, 2005
Which classification for ethmoid malignant tumors involving the anterior skull base?Giulio Cantù, Carlo L Solero, Rosalba Miceli, et al.
Pageof 32

Showing results (151-160 of 311) with videos related to

Sort By:
Pageof 32
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2014
Radiotherapy for unresectable sinonasal cancers: dosimetric comparison of intensity modulated radiation therapy with coplanar and non-coplanar volumetric modulated arc therapyEster Orlandi, Tommaso Giandini, Eva Iannacone, et al.
Oncology|May 22, 2019
PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor AgentsStefano Cavalieri, Federica Perrone, Massimo Milione, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 5, 2018
Lenvatinib-induced renal failure: two first-time case reports and review of literatureStefano Cavalieri, Laura Cosmai, Augusto Genderini, et al.
Journal of Cancer Research and Clinical Oncology|July 4, 2020
A randomized, double-blind, placebo controlled, phase II study to evaluate the efficacy of ginseng in reducing fatigue in patients treated for head and neck cancerMauro Guglielmo, Patricia Di Pede, Salvatore Alfieri, et al.
Cancers|November 14, 2023
Baseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab TreatmentMarco Carlo Merlano, Matteo Paccagnella, Nerina Denaro, et al.
Head & Neck|November 18, 2018
Impact of treatment expertise on the outcome of patients with head and neck cancer treated within 6 randomized trialsPaolo Bossi, Rosalba Miceli, Marco Benasso, et al.
International Journal of Radiation Oncology, Biology, Physics|September 21, 2007
Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring systemMauro Palazzi, Stefano Tomatis, Ester Orlandi, et al.
Oral Oncology|September 20, 2025
Transcriptomic based prognostic model versus TNM 9th edition in HPV-positive oropharyngeal cancerStefano Cavalieri, Ruud H Brakenhoff, C René Leemans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2018
Molecular Alterations and Buparlisib Efficacy in Patients with Squamous Cell Carcinoma of the Head and Neck: Biomarker Analysis from BERIL-1Denis Soulières, Lisa Licitra, Ricard Mesía, et al.
Head & Neck|January 1, 2005
Which classification for ethmoid malignant tumors involving the anterior skull base?Giulio Cantù, Carlo L Solero, Rosalba Miceli, et al.
Pageof 32